Next Science appoints Harry Thomas Hall, IV as new CEO

SYDNEY, AUSTRALIA: Next Science Limited (ASX: NXS), a leading medical technology company dedicated to combating biofilm-based infections in human health, has announced the appointment of Harry Thomas Hall, IV, widely known as “I.V.,” as its new Managing Director and Chief Executive Officer (CEO). I.V. will assume the role of CEO on July 10, 2023. To…